AJP - Heart and Circulatory Physiology, Vol 261, Issue 6 1716-H1726, Copyright © 1991 by American Physiological Society

ARTICLES

Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity

K. Maruyama, C. L. Ye, M. Woo, H. Venkatacharya, L. D. Lines, M. M. Silver and M. Rabinovitch
Department of Cardiology, Hospital for Sick Children, Toronto, Ontario, Canada.

Previously in rats injected with the toxin monocrotaline and administered SC-39026, a serine elastase inhibitor, pulmonary hypertension was decreased in association with reduced muscularization of peripheral pulmonary arteries. To determine whether inhibition of elastolytic activity might prevent this vascular change in other conditions producing pulmonary hypertension, we administered SC-39026 to rats during a 10-day exposure to chronic hypobaric hypoxia. We also measured elastolytic activity in the central pulmonary arteries of rats using [3H]elastin substrate and determined whether there was an increase in activity either as early as 2 days or at completion of the hypoxic exposure, which could be inhibited by SC-39026. to further determine whether the mechanism of muscularization of peripheral arteries is modulated by degradation of elastin or other elastase-susceptible extracellular matrix proteins, we assessed desmosine excretion and ultrastructural alterations in elastin as well as in type IV collagen, fibronectin, and laminin. SC-39026 reduced the number of muscularized arteries and the level of pulmonary arterial pressure during exposure to chronic hypoxia. Elastolytic activity was fourfold higher in central pulmonary arteries 2 days after hypoxia when compared with values in control vessels, and the activity was inhibited by SC-39026. In small peripheral pulmonary arteries there were no significant changes with hypoxia reflected in desmosines or in the immunocytochemistry of elastase-susceptible glycoproteins, with the exception of decreased laminin. This feature was not inhibited by SC-39026. To further assess whether the protective effect of SC-39026 was related to its inhibition of elastase, an extended study was carried out using a different elastase inhibitor, alpha 1-proteinase inhibitor. An even greater reduction in hypoxia-induced pulmonary hypertension and vascular changes was observed with this elastase inhibitor and the latter included medial hypertrophy.

This article has been cited by other articles:

				A. Shifren, A. G. Durmowicz, R. H. Knutsen, G. Faury, and R. P. Mecham Elastin insufficiency predisposes to elevated pulmonary circulatory pressures through changes in elastic artery structure J Appl Physiol, November 1, 2008; 105(5): 1610 - 1619. [Abstract] [Full Text] [PDF]

				S. R. Lammers, P. H. Kao, H. J. Qi, K. Hunter, C. Lanning, J. Albietz, S. Hofmeister, R. Mecham, K. R. Stenmark, and R. Shandas Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1451 - H1459. [Abstract] [Full Text] [PDF]

				Y. Mitani, J. Maruyama, B. H. Jiang, H. Sawada, H. Shimpo, K. Imanaka-Yoshida, Y. Kaneda, Y. Komada, and K. Maruyama Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 142 - 149. [Abstract] [Full Text] [PDF]

				M. Rabinovitch, N. Chesler, and R. C. Molthen Point:Counterpoint: Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature J Appl Physiol, October 1, 2007; 103(4): 1449 - 1451. [Full Text] [PDF]

				Y. Mitani, A. Mutlu, J. C. Russell, D. N. Brindley, J. DeAlmeida, and M. Rabinovitch Dexfenfluramine protects against pulmonary hypertension in rats J Appl Physiol, November 1, 2002; 93(5): 1770 - 1778. [Abstract] [Full Text] [PDF]

				S. H.E. Zaidi, X.-M. You, S. Ciura, M. Husain, and M. Rabinovitch Overexpression of the Serine Elastase Inhibitor Elafin Protects Transgenic Mice From Hypoxic Pulmonary Hypertension Circulation, January 29, 2002; 105(4): 516 - 521. [Abstract] [Full Text] [PDF]

				M. Levi, L. Moons, A. Bouche, S. D. Shapiro, D. Collen, and P. Carmeliet Deficiency of Urokinase-Type Plasminogen Activator-Mediated Plasmin Generation Impairs Vascular Remodeling During Hypoxia-Induced Pulmonary Hypertension in Mice Circulation, April 17, 2001; 103(15): 2014 - 2020. [Abstract] [Full Text] [PDF]

				V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF]

				Y. MITANI, S. H. E. ZAIDI, P. DUFOURCQ, K. THOMPSON, and M. RABINOVITCH Nitric oxide reduces vascular smooth muscle cell elastase activity through cGMP-mediated suppression of ERK phosphorylation and AML1B nuclear partitioning FASEB J, April 1, 2000; 14(5): 805 - 814. [Abstract] [Full Text]

				M. Rabinovitch EVE and beyond, retro and prospective insights Am J Physiol Lung Cell Mol Physiol, July 1, 1999; 277(1): L5 - L12. [Abstract] [Full Text] [PDF]

				J. Maruyama, A. Yokochi, K. Maruyama, and S. Nosaka Acetylcholine-induced endothelium-derived contracting factor in hypoxic pulmonary hypertensive rats J Appl Physiol, May 1, 1999; 86(5): 1687 - 1695. [Abstract] [Full Text] [PDF]

				D. A. Wigle, K. E. Thompson, S. Yablonsky, S. H. E. Zaidi, C. Coulber, P. L. Jones, and M. Rabinovitch AML1-like Transcription Factor Induces Serine Elastase Activity in Ovine Pulmonary Artery Smooth Muscle Cells Circ. Res., August 10, 1998; 83(3): 252 - 263. [Abstract] [Full Text] [PDF]

				H. Christou, A. Yoshida, V. Arthur, T. Morita, and S. Kourembanas Increased Vascular Endothelial Growth Factor Production in the Lungs of Rats with Hypoxia-induced Pulmonary Hypertension Am. J. Respir. Cell Mol. Biol., June 1, 1998; 18(6): 768 - 776. [Abstract] [Full Text]

				Y. Mitani, K. Maruyama, and M. Sakurai Prolonged Administration of L-Arginine Ameliorates Chronic Pulmonary Hypertension and Pulmonary Vascular Remodeling in Rats Circulation, July 15, 1997; 96(2): 689 - 697. [Abstract] [Full Text]

				G. L. Colice, N. Hill, Y.-J. Lee, H. Du, J. Klinger, J. C. Leiter, and L.-C. Ou Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness J Appl Physiol, July 1, 1997; 83(1): 25 - 31. [Abstract] [Full Text] [PDF]

				S. K. Schachtner, J. J. Rome, R. F. Hoyt Jr, K. D. Newman, R. Virmani, and D. A. Dichek In Vivo Adenovirus-Mediated Gene Transfer Via the Pulmonary Artery of Rats Circ. Res., May 1, 1995; 76(5): 701 - 709. [Abstract] [Full Text]

				T. Minamino, H. Christou, C.-M. Hsieh, Y. Liu, V. Dhawan, N. G. Abraham, M. A. Perrella, S. A. Mitsialis, and S. Kourembanas Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia PNAS, July 17, 2001; 98(15): 8798 - 8803. [Abstract] [Full Text] [PDF]